Clinical trial
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of…
NCT00063297 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00063297 |
|---|---|
| Title | Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | R209130 |
| Enrollment | 180 |
| Start date | May 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Jun 26, 2003 |
| Last update posted | Aug 28, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: